Cargando…

Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model

Background: Spontaneous Reporting Systems (SRSs) are passive systems composed of reports of suspected Adverse Drug Events (ADEs), and are used for Pharmacovigilance (PhV), namely, drug safety surveillance. Exploration of analytical methodologies to enhance SRS-based discovery will contribute to more...

Descripción completa

Detalles Bibliográficos
Autores principales: Narushima, Daichi, Kawasaki, Yohei, Takamatsu, Shoji, Yamada, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793323/
https://www.ncbi.nlm.nih.gov/pubmed/26989609
http://dx.doi.org/10.7717/peerj.1753
_version_ 1782421384880717824
author Narushima, Daichi
Kawasaki, Yohei
Takamatsu, Shoji
Yamada, Hiroshi
author_facet Narushima, Daichi
Kawasaki, Yohei
Takamatsu, Shoji
Yamada, Hiroshi
author_sort Narushima, Daichi
collection PubMed
description Background: Spontaneous Reporting Systems (SRSs) are passive systems composed of reports of suspected Adverse Drug Events (ADEs), and are used for Pharmacovigilance (PhV), namely, drug safety surveillance. Exploration of analytical methodologies to enhance SRS-based discovery will contribute to more effective PhV. In this study, we proposed a statistical modeling approach for SRS data to address heterogeneity by a reporting time point. Furthermore, we applied this approach to analyze ADEs of incretin-based drugs such as DPP-4 inhibitors and GLP-1 receptor agonists, which are widely used to treat type 2 diabetes. Methods: SRS data were obtained from the Japanese Adverse Drug Event Report (JADER) database. Reported adverse events were classified according to the MedDRA High Level Terms (HLTs). A mixed effects logistic regression model was used to analyze the occurrence of each HLT. The model treated DPP-4 inhibitors, GLP-1 receptor agonists, hypoglycemic drugs, concomitant suspected drugs, age, and sex as fixed effects, while the quarterly period of reporting was treated as a random effect. Before application of the model, Fisher’s exact tests were performed for all drug-HLT combinations. Mixed effects logistic regressions were performed for the HLTs that were found to be associated with incretin-based drugs. Statistical significance was determined by a two-sided p-value <0.01 or a 99% two-sided confidence interval. Finally, the models with and without the random effect were compared based on Akaike’s Information Criteria (AIC), in which a model with a smaller AIC was considered satisfactory. Results: The analysis included 187,181 cases reported from January 2010 to March 2015. It showed that 33 HLTs, including pancreatic, gastrointestinal, and cholecystic events, were significantly associated with DPP-4 inhibitors or GLP-1 receptor agonists. In the AIC comparison, half of the HLTs reported with incretin-based drugs favored the random effect, whereas HLTs reported frequently tended to favor the mixed model. Conclusion: The model with the random effect was appropriate for analyzing frequently reported ADEs; however, further exploration is required to improve the model. The core concept of the model is to introduce a random effect of time. Modeling the random effect of time is widely applicable to various SRS data and will improve future SRS data analyses.
format Online
Article
Text
id pubmed-4793323
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-47933232016-03-17 Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model Narushima, Daichi Kawasaki, Yohei Takamatsu, Shoji Yamada, Hiroshi PeerJ Drugs and Devices Background: Spontaneous Reporting Systems (SRSs) are passive systems composed of reports of suspected Adverse Drug Events (ADEs), and are used for Pharmacovigilance (PhV), namely, drug safety surveillance. Exploration of analytical methodologies to enhance SRS-based discovery will contribute to more effective PhV. In this study, we proposed a statistical modeling approach for SRS data to address heterogeneity by a reporting time point. Furthermore, we applied this approach to analyze ADEs of incretin-based drugs such as DPP-4 inhibitors and GLP-1 receptor agonists, which are widely used to treat type 2 diabetes. Methods: SRS data were obtained from the Japanese Adverse Drug Event Report (JADER) database. Reported adverse events were classified according to the MedDRA High Level Terms (HLTs). A mixed effects logistic regression model was used to analyze the occurrence of each HLT. The model treated DPP-4 inhibitors, GLP-1 receptor agonists, hypoglycemic drugs, concomitant suspected drugs, age, and sex as fixed effects, while the quarterly period of reporting was treated as a random effect. Before application of the model, Fisher’s exact tests were performed for all drug-HLT combinations. Mixed effects logistic regressions were performed for the HLTs that were found to be associated with incretin-based drugs. Statistical significance was determined by a two-sided p-value <0.01 or a 99% two-sided confidence interval. Finally, the models with and without the random effect were compared based on Akaike’s Information Criteria (AIC), in which a model with a smaller AIC was considered satisfactory. Results: The analysis included 187,181 cases reported from January 2010 to March 2015. It showed that 33 HLTs, including pancreatic, gastrointestinal, and cholecystic events, were significantly associated with DPP-4 inhibitors or GLP-1 receptor agonists. In the AIC comparison, half of the HLTs reported with incretin-based drugs favored the random effect, whereas HLTs reported frequently tended to favor the mixed model. Conclusion: The model with the random effect was appropriate for analyzing frequently reported ADEs; however, further exploration is required to improve the model. The core concept of the model is to introduce a random effect of time. Modeling the random effect of time is widely applicable to various SRS data and will improve future SRS data analyses. PeerJ Inc. 2016-03-08 /pmc/articles/PMC4793323/ /pubmed/26989609 http://dx.doi.org/10.7717/peerj.1753 Text en © 2016 Narushima et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Drugs and Devices
Narushima, Daichi
Kawasaki, Yohei
Takamatsu, Shoji
Yamada, Hiroshi
Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model
title Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model
title_full Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model
title_fullStr Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model
title_full_unstemmed Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model
title_short Adverse events associated with incretin-based drugs in Japanese spontaneous reports: a mixed effects logistic regression model
title_sort adverse events associated with incretin-based drugs in japanese spontaneous reports: a mixed effects logistic regression model
topic Drugs and Devices
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793323/
https://www.ncbi.nlm.nih.gov/pubmed/26989609
http://dx.doi.org/10.7717/peerj.1753
work_keys_str_mv AT narushimadaichi adverseeventsassociatedwithincretinbaseddrugsinjapanesespontaneousreportsamixedeffectslogisticregressionmodel
AT kawasakiyohei adverseeventsassociatedwithincretinbaseddrugsinjapanesespontaneousreportsamixedeffectslogisticregressionmodel
AT takamatsushoji adverseeventsassociatedwithincretinbaseddrugsinjapanesespontaneousreportsamixedeffectslogisticregressionmodel
AT yamadahiroshi adverseeventsassociatedwithincretinbaseddrugsinjapanesespontaneousreportsamixedeffectslogisticregressionmodel